Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 2
1987 4
1988 4
1989 5
1990 6
1991 7
1992 5
1993 12
1994 9
1995 9
1996 13
1997 17
1998 15
1999 18
2000 16
2001 11
2002 14
2003 24
2004 20
2005 9
2006 15
2007 13
2008 7
2009 10
2010 14
2011 12
2012 4
2014 2
2015 1
2020 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

286 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: rowinsky ek. N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422. N Engl J Med. 2006. PMID: 16467544 Free article. Clinical Trial.
Paclitaxel (taxol).
Rowinsky EK, Donehower RC. Rowinsky EK, et al. N Engl J Med. 1995 Apr 13;332(15):1004-14. doi: 10.1056/NEJM199504133321507. N Engl J Med. 1995. PMID: 7885406 Review. No abstract available.
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: rowinsky ek. Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Lancet Oncol. 2010. PMID: 19897418 Clinical Trial.
Neurotoxicity of Taxol.
Rowinsky EK, Chaudhry V, Cornblath DR, Donehower RC. Rowinsky EK, et al. J Natl Cancer Inst Monogr. 1993;(15):107-15. J Natl Cancer Inst Monogr. 1993. PMID: 7912516 Review.
Taxol: a novel investigational antimicrotubule agent.
Rowinsky EK, Cazenave LA, Donehower RC. Rowinsky EK, et al. J Natl Cancer Inst. 1990 Aug 1;82(15):1247-59. doi: 10.1093/jnci/82.15.1247. J Natl Cancer Inst. 1990. PMID: 1973737 Review.
Regulation of c-Raf-1: therapeutic implications.
Beeram M, Patnaik A, Rowinsky EK. Beeram M, et al. Among authors: rowinsky ek. Clin Adv Hematol Oncol. 2003 Aug;1(8):476-81. Clin Adv Hematol Oncol. 2003. PMID: 16258435 Review.
286 results